Alkermes (ALKS)
Healthcare · Drug Manufacturers - Specialty & Generic
1 member of Congress has disclosed 2 trades in Alkermes (ALKS) since 2026: 2 buys and 0 sales. The most recent was disclosed on Oct 12, 2026.
- Trades disclosed
- 2
- Members trading
- 1
- Buys / sells
- 2 / 0
- Reported value
- $16K–$65K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at ALKS
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
ALKS: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
ALKS: Financial results
Filed 8-K for an event or period dated 2026-11-03. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
ALKS: Company disclosure · Other company developments
Filed 8-K for an event or period dated 2026-09-21. Company disclosure; Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
Who traded ALKS
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)2 buys · 0 sales20Oct 12, 2026
All trades
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Sep 29, 2026 · disclosed Oct 12, 2026
- Sep 4, 2026$15K–$50K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$15K–$50K · Traded Jul 30, 2026 · disclosed Sep 4, 2026
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.